Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,412 | 134,654 | 84,337 | 103,388 | 108,597 |
| Receivables | N/A | 6,418 | N/A | N/A | N/A |
| Inventories | 104 | N/A | N/A | N/A | N/A |
| Other current assets | 1,323 | 0 | 3,243 | 4,830 | 2,485 |
| TOTAL | $118,089 | $145,338 | $87,580 | $108,218 | $113,017 |
| Non-Current Assets | |||||
| PPE Net | 736 | 138 | 128 | 40 | 18 |
| Investments And Advances | 457 | 456 | 469 | 266 | 243 |
| Intangibles | 46,572 | 56,078 | 57,228 | 56,053 | 50,289 |
| Other Non-Current Assets | 4,372 | 2,625 | 1,028 | 722 | 637 |
| TOTAL | $52,136 | $59,297 | $58,852 | $57,080 | $51,186 |
| Total Assets | $170,226 | $204,634 | $146,432 | $165,298 | $164,203 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,925 | 8,661 | 7,046 | 6,873 | 5,867 |
| Accrued Expenses | 6,244 | 6,314 | 6,398 | 6,298 | 4,511 |
| Other current liabilities | 1,481 | 1,231 | 1,069 | 800 | 1,078 |
| TOTAL | $15,793 | $16,206 | $14,513 | $13,972 | $11,513 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,057 | 21,685 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 8,426 | 9,950 | 8,701 | 7,952 | 7,034 |
| TOTAL | $36,867 | $39,114 | $16,502 | $16,371 | $15,754 |
| Total Liabilities | $52,660 | $55,321 | $31,015 | $30,343 | $27,266 |
| Shareholders' Equity | |||||
| Common Shares | 244 | 242 | 238 | 238 | 218 |
| Retained earnings | -166,339 | -137,940 | -143,346 | -124,222 | -100,127 |
| Other shareholders' equity | -3,146 | 3,318 | 3,907 | 4,391 | 4,329 |
| TOTAL | $117,566 | $149,314 | $115,417 | $134,955 | $136,937 |
| Total Liabilities And Equity | $170,226 | $204,634 | $146,432 | $165,298 | $164,203 |